Logo Logo

Publications by Krauter, J.

Up a level
Export as [feed] RSS 1.0 [feed] RSS 2.0
Group by: Item Type | Date
Number of items: 6.

Journal article

Wattad, M.; Weber, D.; Döhner, K.; Krauter, J.; Gaidzik, V. I.; Paschka, P.; Heuser, M.; Thol, F.; Kindler, T.; Lübbert, M.; Salih, H. R.; Kündgen, A.; Horst, H.-A.; Brossart, P.; Götze, K.; Nachbaur, D.; Köhne, C.-H.; Ringhoffer, M.; Wulf, G.; Held, G.; Salwender, H.; Benner, A.; Ganser, A.; Döhner, H.; Schlenk, R. F. (2017): Impact of salvage regimens on response and overall survival in acute myeloid leukemia with induction failure. In: Leukemia, Vol. 31, No. 6: pp. 1306-1313

Theis, F.; Corbacioglu, A.; Gaidzik, V. I.; Paschka, P.; Weber, D.; Bullinger, L.; Schlegelberger, B.; Göhring, G.; Köhne, C.-H.; Krämer, D.; Germing, U.; Brossart, P.; Horst, H.-A.; Haase, D.; Götze, K.; Ringhoffer, M.; Fiedler, W.; Nachbaur, D.; Kindler, T.; Held, G.; Lübert, M.; Wattad, M.; Salih, H. R.; Krauter, J.; Heuser, M.; Thol, F.; Ganser, A.; Döhner, H.; Schlenk, R. F.; Döhner, K. (2017): Clinical Impact of TET2 Mutations in Acute Myeloid Leukemia Patients Harboring CEBPA Mutations: A Study of the AML Study Group (AMLSG). In: Hämatologica, Vol. 102: pp. 203-204

Würstlein, R.; Gluz, O.; Kates, R.; Persoon, M.; Wasmayr, M.; Knauer, M.; Koplmüller, R.; Grischke, E.-M.; Schem, C.; Thill, M.; Hasmüller, S.; Griesinger, F.; Köhler, A.; Otremba, B.; Schindlbeck, C.; Reimer, T.; Krauter, J.; Tome, O.; Otto, F.; Friedrichs, K.; Albert, U.-S.; Gebauer, G.; Nitz, U.; Harbeck, N. (2017): Results of multigene assay (MammaPrint (R)) and molecular subtyping (BluePrint (R)) substantially impact treatment decision making in early breast cancer: Final analysis of the WSG PRIME decision impact study. In: Cancer Research, Vol. 77

Theis, F.; Corbacioglu, A.; Gaidzik, V. I.; Paschka, P.; Weber, D.; Bullinger, L.; Heuser, M.; Ganser, A.; Thol, F.; Schlegelberger, B.; Göhring, G.; Köhne, C.-H.; Germing, U.; Brossart, P.; Horst, H.-A.; Haase, D.; Götze, K.; Ringhoffer, M.; Fiedler, W.; Nachbaur, D.; Kindler, T.; Held, G.; Lübbert, M.; Wattad, M.; Salih, H. R.; Krauter, J.; Döhner, H.; Schlenk, R. F.; Doehner, K. (2016): Clinical impact of GATA2 mutations in acute myeloid leukemia patients harboring CEBPA mutations: a study of the AML study group. In: Leukemia, Vol. 30, No. 11: pp. 2248-2250

Büchner, T.; Schlenk, R. F.; Schaich, M.; Doehner, K.; Krahl, R.; Krauter, J.; Heil, G.; Krug, U.; Sauerland, M. C.; Heinecke, A.; Späth, Daniela; Kramer, M.; Scholl, S.; Berdel, W. E.; Hiddemann, Wolfgang; Hoelzer, D.; Hehlmann, R.; Hasford, Joerg; Hoffmann, V. S.; Doehner, H.; Ehninger, G.; Ganser, A.; Niederwieser, D. W.; Pfirrmann, Markus (2012): Acute Myeloid Leukemia (AML): Different Treatment Strategies Versus a Common Standard Arm‐Combined Prospective Analysis by the German AML Intergroup. In: Journal of Clinical Oncology, Vol. 30, No. 29: pp. 3604-3610

Messerer, D.; Engel, Jutta; Hasford, Joerg; Schaich, M.; Ehninger, G.; Sauerland, C.; Büchner, T.; Schumacher, A.; Krahl, R.; Niederwieser, D. W.; Krauter, J.; Ganser, A.; Creutzig, U.; Doehner, H.; Schlenk, R. F. (2008): Impact of different post-remission strategies on quality of life in patients with acute myeloid leukemia. In: Haematologica, Vol. 93, No. 6: pp. 826-833

This list was generated on Thu Aug 13 01:24:09 2020 CEST.